Illumina SVP Unloads $340,000 in Stock (ILMN)
Illumina (NASDAQ:ILMN) SVP Nicholas Naclerio sold 4,000 shares of the company’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $85.00, for a total transaction of $340,000.00. Following the transaction, the senior vice president now directly owns 24,559 shares of the company’s stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on ILMN. Analysts at Wells Fargo & Co. initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Monday, September 9th. They set an “outperform” rating on the stock. Separately, analysts at Bank of America Corp. set a $90.00 price target on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 22nd. They now have a “buy” rating on the stock. Finally, analysts at Janney Montgomery Scott initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock.
One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have given a buy rating to the stock. Illumina currently has an average rating of “Hold” and a consensus target price of $73.81.
Illumina (NASDAQ:ILMN) traded down 1.40% on Wednesday, hitting $83.25. The stock had a trading volume of 1,090,796 shares. Illumina has a one year low of $44.78 and a one year high of $85.81. The stock has a 50-day moving average of $79.53 and a 200-day moving average of $69.08. The company has a market cap of $10.416 billion and a price-to-earnings ratio of 99.33.
Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter in the previous year, the company posted $0.40 earnings per share. The company’s revenue for the quarter was up 23.3% on a year-over-year basis. Analysts expect that Illumina will post $1.72 EPS for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.